Well said CP this is why I truly believe a large partnership is announced prior the look ins and almost certain before the second look in.
The risk for BMY GILD MRK RHHBY PFE is that AZN is much closer at finalizing a deal. These companies are NOT afraid of putting down a couple billion to get exclusive rights to Bavituximab and have first refusal for buyout of the whole PS platform.
These companies ARE afraid of loosing market share in the immuno oncology race.
Announce full enrollment Mr King I have a lot of big money investors wanting to jump in.
There will be no more naked shorting I assure you.
Any thoughts on why the BPs currently in the IO arena aren't buying PPHM stock? At the current PPPHM share price, it's chump change for a BP with 20 billion in cash on the the books. A BP who directly or indirectly owned a large chunk of PPHM stock certainly would have more negotiation leverage to get in on Bavi Combo. Why let Steve King dictate terms when a BP could easily become the largest shareholder at prices significantly below $10 per share.